Social, political, and epistemological aspects of genetics and genomics

Community Genetics

Volumn 9, Issue 3, 2006, Pages 137-141

  Lock, Margaret ^a   Cox, Susan ^b   D'Agincourt Canning, Lori ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Clinical and research ethics; Genetic knowledge; Genomic technologies

Indexed keywords

CONFERENCE PAPER; EPISTEMOLOGY; GENE; GENETIC PROCEDURES; GENOMICS; GOVERNMENT; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MORALITY; POLITICS; POPULATION GENETICS; PRIORITY JOURNAL; RESEARCH ETHICS; SOCIAL ASPECT;

BIOETHICS; GENETICS, MEDICAL; GENOMICS; HUMANS; POLITICS; PUBLIC POLICY;

EID: 33744950996     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092649     Document Type: Conference Paper

References (21)

1. Snow CP: The Two Cultures and the Scientific Revolution. New York, Cambridge University Press, 1959.
2. Snow CP: Two Cultures: And a Second Look. Cambridge, Cambridge University Press, 1964.
3. Wynne B: Public uptake of science: a case for institutional reflexivity. Public Understand Sci 1993;2:321-337.
4. Irwin A, Wynne B: Misunderstanding Science: The Public Reconstruction of Science and Technology. Cambridge, Cambridge University Press, 1996.
5. Kerr A, Cunningham-Burley S, Amos A: The new genetics and health: mobilizing lay expertise. Public Understand Sci 1998;7:41-60.
6. MacIntyre S: The public understanding of science or the scientific understanding of the public? A review of the social context of the 'new genetics'. Public Understand Sci 1995;4:223-232.
7. Healy D: Let Them Eat Prozac. Toronto, James Lorimer, 2003.
8. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004;172:1297-1301.
9. Fletcher SW, Colditz GA: Failure of estrogen plus progestin therapy for prevention. JAMA 2002;288:321-333.
10. Davis D: Groups, communities and contested identities in genetic research. Hastings Cent Rep 2000;30:38-45.
11. Weijer C: The need to protect the community in research. Camb Q Healthc Ethics 1999;8:501-513.
12. Burgess MM, Brunger F: Negotiating collective acceptability of health research; in McDonald M (ed): Governance of Health Research Involving Human Subjects. Ottawa, Law Commission of Canada, 2000, pp 117-151.
13. Burke W, Pinsky LE, Press NA: Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Gen 2001;106:233-240.
14. Cox SM, Starzomski RC: Genes and geneticization? The social construction of autosomal dominant polycystic kidney disease. New Genet Soc 2004;23:137-166.
15. Lock M, Lloyd S, Prest J: Genetic susceptibility and Alzheimer's disease: the penetrance and uptake of genetic knowledge; in Leibing A, Cohen L (eds): Anthropological Approaches to Alzheimer's Disease. New Jersey, Rutgers University Press, in press.
16. Rapp R: Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America. New York, Routledge, 2000.
17. Hallowell N, Statham H, Murton F, Green J, Richards M: 'Talking about chance': the presentation of risk information during genetic counseling for breast and ovarian cancer. J Genet Couns 1997;6:269-286.
18. d'Agincourt-Canning L: The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 2005;14:55-69.
19. Cox SM, McKellin WH: 'There's this thing in our family': predictive testing and the social construction of risk for Huntington disease. Sociol Health Illness 1999;21:622-646.
20. d'Agincourt-Canning L: Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001;15:231-247.
21. Symposium on the 25th anniversary of the Asilomar conference, special issue. Perspect Biol Med 2001;44:159.